Clinical Trial Update: Cannabis for Spasticity in Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating cannabis for spasticity in multiple sclerosis was terminated, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cannabis (Cannabis)

Snippet

Sponsor: University of California, Davis | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-05-18